Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

BackgroundMicroRNAs (miRNAs) are small non-coding RNAs with a vast array of biological functions, including the regulation of gene expression. It remains to be determined whether circulatory miRNAs are associated with markers of neurodegeneration in plasma (neurofilament light chain (NfL), total tau (t-tau) and amyloid beta (Aβ)), before the clinical onset of dementia.MethodsWe included 1959 dementia-free participants of the population-based Rotterdam Study (mean age 70.5 years, 56.8% women), who visited the research center for blood sampling between 2002 and 2005. Plasma levels of 591 well-expressed circulatory miRNAs were measured by the HTG EdgeSeq Whole Transcriptome Assay, while t-tau, NfL, Aβ-40 and Aβ-42 were analysed using the Simoa NF-light® and N3PA assays. We used linear regression models to determine associations between circulatory miRNAs and markers of neurodegeneration, while adjusting for potential confounders. To account for the high-dimensional structure of miRNAs, we repeated the analysis using elastic net regularization models. Finally, we performed a post-hoc in-silico analysis to study the common miRNAs between all four biomarkers, their potential target genes and their link to dementia.ResultsWe found 58 miRNAs significantly associated with t-tau, 96 miRNAs with NfL, 158 miRNAs with Aβ-40, and 83 miRNAs with Aβ-42 (all with false discovery rate (FDR)-adjusted p-value ≤ 0.05). Notably, twelve miRNAs (miR-3141, miR-7107-5p, miR-146a-5p, miR-6887-5p, miR-221-3p, miR-4681, miR-6810-3p, miR-6821-5p, miR-654-5p, miR-4486, miR-4478, miR-326) were shared among all four neurodegeneration biomarkers. Subsequent in-silico analysis showed that many of these miRNAs are expressed across various brain regions, where they have important putative target genes (e.g., SORT1, TSPAN14, ADAM17, KLF16, WDR12). A pathway analysis highlighted the Notch signalling cascade, with possible implications for the amyloid precursor protein (APP).ConclusionsThis population-based study revealed many circulatory miRNAs associated with biomarkers of neurodegeneration, including 12 miRNAs that were common to all, potentially offering valuable insights into regulatory pathways underlying dementia. These miRNAs could be valuable for monitoring dementia and developing effective diagnostic or therapeutic strategies.

More information Original publication

DOI

10.1186/s13195-025-01831-6

Type

Journal article

Publication Date

2025-07-01T00:00:00+00:00

Volume

17

Addresses

D, e, p, a, r, t, m, e, n, t, , o, f, , E, p, i, d, e, m, i, o, l, o, g, y, ,, , E, r, a, s, m, u, s, , U, n, i, v, e, r, s, i, t, y, , M, e, d, i, c, a, l, , C, e, n, t, e, r, ,, , D, r, ., , M, o, l, e, w, a, t, e, r, p, l, e, i, n, , 4, 0, ,, , R, o, t, t, e, r, d, a, m, ,, , 3, 0, 1, 5, , G, D, ,, , t, h, e, , N, e, t, h, e, r, l, a, n, d, s, .

Keywords

Humans, Neurodegenerative Diseases, Neurofilament Proteins, Peptide Fragments, tau Proteins, MicroRNAs, Aged, Aged, 80 and over, Middle Aged, Female, Male, Amyloid beta-Peptides, Biomarkers, Circulating MicroRNA